SE387640B - Analogiforfarande for framstellning av benso(c)(1,6)naftyridiner - Google Patents

Analogiforfarande for framstellning av benso(c)(1,6)naftyridiner

Info

Publication number
SE387640B
SE387640B SE613471A SE613471A SE387640B SE 387640 B SE387640 B SE 387640B SE 613471 A SE613471 A SE 613471A SE 613471 A SE613471 A SE 613471A SE 387640 B SE387640 B SE 387640B
Authority
SE
Sweden
Prior art keywords
naftyridines
benzo
preparation
analogical procedure
analogical
Prior art date
Application number
SE613471A
Other languages
English (en)
Inventor
H Ott
R Suess
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH708970A external-priority patent/CH527822A/de
Priority claimed from CH708670A external-priority patent/CH527196A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE387640B publication Critical patent/SE387640B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE613471A 1970-05-13 1971-05-12 Analogiforfarande for framstellning av benso(c)(1,6)naftyridiner SE387640B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH708970A CH527822A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate
CH708670A CH527196A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphthyridinderivate

Publications (1)

Publication Number Publication Date
SE387640B true SE387640B (sv) 1976-09-13

Family

ID=25700728

Family Applications (1)

Application Number Title Priority Date Filing Date
SE613471A SE387640B (sv) 1970-05-13 1971-05-12 Analogiforfarande for framstellning av benso(c)(1,6)naftyridiner

Country Status (14)

Country Link
JP (1) JPS5432799B1 (sv)
AT (1) AT326674B (sv)
CA (1) CA970377A (sv)
CS (2) CS167202B2 (sv)
DE (1) DE2123328A1 (sv)
DK (1) DK134488B (sv)
ES (1) ES391026A1 (sv)
FI (1) FI52089C (sv)
FR (1) FR2100649B1 (sv)
GB (1) GB1361441A (sv)
NL (1) NL7106502A (sv)
PL (1) PL76913B1 (sv)
SE (1) SE387640B (sv)
SU (1) SU423296A3 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
NL7314396A (sv) * 1972-10-26 1974-05-01
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine
ATE232864T1 (de) * 1997-06-03 2003-03-15 Altana Pharma Ag Benzonaphthyridine
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
CA2565953A1 (en) * 2004-05-12 2005-11-24 Pfizer Products Inc. Piperidine derivatives as nk1 and nk3 antagonists
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcアゴニストの調製方法
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Also Published As

Publication number Publication date
ATA412471A (de) 1975-03-15
SU423296A3 (ru) 1974-04-05
PL76913B1 (en) 1975-02-28
CA970377A (en) 1975-07-01
GB1361441A (en) 1974-07-24
JPS5432799B1 (sv) 1979-10-16
FI52089B (sv) 1977-02-28
DE2123328A1 (de) 1971-12-02
ES391026A1 (es) 1974-04-01
DK134488B (da) 1976-11-15
AT326674B (de) 1975-12-29
FI52089C (sv) 1977-06-10
FR2100649A1 (sv) 1972-03-24
FR2100649B1 (sv) 1974-08-30
CS167202B2 (sv) 1976-04-29
DK134488C (sv) 1977-05-16
NL7106502A (sv) 1971-11-16
CS162753B2 (sv) 1975-07-15

Similar Documents

Publication Publication Date Title
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE393381B (sv) Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat
SE387640B (sv) Analogiforfarande for framstellning av benso(c)(1,6)naftyridiner
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE390304B (sv) Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
DK132174C (da) Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE380527B (sv) Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE398501B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE396599B (sv) Forfarande for framstellning av 1,2-di-substituerade hydraziner
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
SE382057B (sv) Forfarande for framstellning av n-hydroxialkylpiperazinylderivat
SE382062B (sv) Forfarande for framstellning av acylpropandiol-(1,3)-fosforsyra-kolinestrar
SE397522B (sv) Forfarande for framstellning av penicillamin och dess homologer, utgaende fran substituerade 5,5-dialkyl-tiazolidin-4-karbonitriler
SE389103B (sv) Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro
SE399257B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat